CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More

Sarah Klein, PhD

Sarah Klein, PhD

Sarah Klein, PhD, is the Associate Director of the Multiplex Assays Group at CST. This group was instrumental in the development and validation of SignalStar Multiplex IHC. Dr Klein has been with CST for seven years developing antibody-based solutions in the fields of immunology and oncology. She performed her postdoctoral research at Dana Farber Cancer Institute in Boston, MA, and her doctoral research at MD Anderson Cancer Center in Houston, TX, studying the mechanisms of action for immunotherapeutics used in the treatment of cancer, particularly glioblastomas.

Recent Posts:

SignalStar™ Multiplex IHC: Speed Your Spatial Biology Research with Ready-to-Use, 8-Plex Antibody Panels

Enabled by recent advances in sequencing, mass spectrometry, and fluorescence microscopy, spatial bi...
Sarah Klein, PhD Sep 12, 2023

    Related Posts